Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Olive

Showing results (61-70 of 276) with videos related to

Pageof 28
Sort By:
The Lancet. Oncology|January 1, 2004
Immunobiology of haematological malignant disorders: the basis for novel immunotherapy protocolsRégis T Costello, Cyril Fauriat, Jérôme Rey, et al.
European Journal of Dermatology : EJD|September 6, 2022
Occurrence of Sézary syndrome following the initiation of anti-IL-5 treatmentMathilde Barré, Florent Amatore, Morgan Avenin, et al.
Immunobiology|June 3, 2008
Blood dendritic cells in patients with chronic lymphocytic leukaemiaNaira Ben Mami, Mohamad Mohty, Thérèse Aurran-Schleinitz, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2021
Occurrence of Sézary syndrome following the initiation of anti-IL-5 drugMathilde Barré, Florent Amatore, Morgan Avenin, et al.
Journal of Medical Virology|November 20, 2013
Clinical and analytical relevance of NNRTIs minority mutations on viral failure in HIV-1 infected patientsSofiane Mohamed, Sophie Ravet, Claire Camus, et al.
Frontiers in Immunology|May 5, 2018
Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 InhibitorsMarjorie Faure, Philippe Rochigneux, Daniel Olive, et al.
Journal of Leukocyte Biology|September 29, 2020
Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapyRaynier Devillier, Anne-Sophie Chrétien, Thomas Pagliardini, et al.
European Journal of Immunology|November 19, 2004
LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiationThomas Duhen, Christine Pasero, Françoise Mallet, et al.
Frontiers in Immunology|June 6, 2018
Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor MicroenvironmentEtienne D Foucher, Clément Ghigo, Salem Chouaib, et al.
Medecine Sciences : M/S|July 3, 2020
[PD-L1 glycosylation under the spotlights]Daniel Olive, Anne-Sophie Chrétien, Raynier Devillier, et al.
Pageof 28

Showing results (61-70 of 276) with videos related to

Sort By:
Pageof 28
The Lancet. Oncology|January 1, 2004
Immunobiology of haematological malignant disorders: the basis for novel immunotherapy protocolsRégis T Costello, Cyril Fauriat, Jérôme Rey, et al.
European Journal of Dermatology : EJD|September 6, 2022
Occurrence of Sézary syndrome following the initiation of anti-IL-5 treatmentMathilde Barré, Florent Amatore, Morgan Avenin, et al.
Immunobiology|June 3, 2008
Blood dendritic cells in patients with chronic lymphocytic leukaemiaNaira Ben Mami, Mohamad Mohty, Thérèse Aurran-Schleinitz, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2021
Occurrence of Sézary syndrome following the initiation of anti-IL-5 drugMathilde Barré, Florent Amatore, Morgan Avenin, et al.
Journal of Medical Virology|November 20, 2013
Clinical and analytical relevance of NNRTIs minority mutations on viral failure in HIV-1 infected patientsSofiane Mohamed, Sophie Ravet, Claire Camus, et al.
Frontiers in Immunology|May 5, 2018
Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 InhibitorsMarjorie Faure, Philippe Rochigneux, Daniel Olive, et al.
Journal of Leukocyte Biology|September 29, 2020
Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapyRaynier Devillier, Anne-Sophie Chrétien, Thomas Pagliardini, et al.
European Journal of Immunology|November 19, 2004
LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiationThomas Duhen, Christine Pasero, Françoise Mallet, et al.
Frontiers in Immunology|June 6, 2018
Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor MicroenvironmentEtienne D Foucher, Clément Ghigo, Salem Chouaib, et al.
Medecine Sciences : M/S|July 3, 2020
[PD-L1 glycosylation under the spotlights]Daniel Olive, Anne-Sophie Chrétien, Raynier Devillier, et al.
Pageof 28